Q3 2024 Earnings Estimate for Sarepta Therapeutics, Inc. Issued By Zacks Research (NASDAQ:SRPT)
Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) – Equities research analysts at Zacks Research boosted their Q3 2024 earnings per share estimates for shares of Sarepta Therapeutics in a research note issued on Thursday, January 11th. Zacks Research analyst S. Ganoria now anticipates that the biotechnology company will earn $0.29 per share for the quarter, […]
More Stories
UFP Industries (NASDAQ:UFPI) Reaches New 1-Year High – Time to Buy?
UFP Industries, Inc. (NASDAQ:UFPI – Get Free Report) reached a new 52-week high on Monday . The stock traded as...
Uber Technologies (NYSE:UBER) Trading 1.9% Higher on Analyst Upgrade
Uber Technologies, Inc. (NYSE:UBER – Get Free Report) shares traded up 1.9% during trading on Monday after Tigress Financial raised...
Sixth Street Specialty Lending (NYSE:TSLX) Trading Up 0.9% – Time to Buy?
Sixth Street Specialty Lending, Inc. (NYSE:TSLX – Get Free Report)’s share price traded up 0.9% during trading on Monday ....
Diana Shipping Inc. to Issue Quarterly Dividend of $0.01 (NYSE:DSX)
Diana Shipping Inc. (NYSE:DSX – Get Free Report) announced a quarterly dividend on Monday, November 25th,NASDAQ Dividends reports. Stockholders of...
Agilent Technologies (NYSE:A) Updates FY 2025 Earnings Guidance
Agilent Technologies (NYSE:A – Get Free Report) issued an update on its FY 2025 earnings guidance on Monday morning. The...
Jamieson Wellness (TSE:JWEL) Sets New 52-Week High After Analyst Upgrade
Shares of Jamieson Wellness Inc. (TSE:JWEL – Get Free Report) reached a new 52-week high during trading on Monday after...